TY - JOUR AU - Rani, Sweta AU - Mistri, Pallab Kumar PY - 2019/05/03 Y2 - 2024/03/29 TI - Oxygen Saturation as a Predictor of Adverse Maternal Outcomes in Women with Preeclampsia JF - Birat Journal of Health Sciences JA - Birat J. Health Sci. VL - 4 IS - 1 SE - Original Research Articles DO - 10.3126/bjhs.v4i1.23926 UR - https://www.nepjol.info/index.php/bjhs/article/view/23926 SP - 582-585 AB - <p><strong>Introduction: </strong>In preeclampsia, hypoxemia may result from a number of mechanisms. Preeclampsia remains a complex and poorly understood disease. Currently, there are no reliable predictors of preeclampsia for early diagnosis to avoid adverse maternal or perinatal outcomes.</p><p><strong>Objective: </strong>The objective was to evaluate the efficacy of oxygen saturation (SpO<sub>2</sub>) as a predictor of adverse maternal outcome in women with preeclampsia.</p><p><strong>Methodology: </strong>We conducted the cross-sectional study on 182 preeclamptic women selected by random sampling technique. They were divided into two groups on the basis of oxygen saturation: 29 preeclamptic women (Group L) having oxygen saturation 95% or below and 153 women (Group H) having oxygen saturation 96% or above. The groups were statistically compared with respect to age, gestational age, proteinuria, severity of hypertension and developing different adverse effect of preeclampsia. Women with any medical disorders were excluded.</p><p><strong>Results: </strong>After statistical analysis, it was seen that the women having Spo<sub>2</sub> ≤ 95% (L-Group) had experienced more adverse 2 outcomes. They were more hypertensive and more proteinuric, had higher liver enzyme levels, lower platelet counts, and were more likely to have experienced cardio-respiratory symptoms. Women with adverse outcomes were also more likely to have had therapeutic interventions, including corticosteroids, antihypertensives, and magnesium sulphate.</p><p><strong>Conclusion: </strong>Women having SpO<sub>2</sub> ≤ 95% (L-Group) had more adverse 2 outcomes in comparison to SpO<sub>2</sub> ≥96%(H-Group).</p> ER -